Use the following information to answer Questions 29-33: Pharma Inc. has 1.5 million shares outstanding, trading at $50 per share. Pharma Inc. is considering two competing merger offers: . The Vax Co offer Vax Co is offering Pharma Inc's stockholders a cash payment of $55 dollars per Pharma Inc. share. Vax Co. has 40 million shares outstanding, trading at $10 dollars per share. Vax Co, estimates, the synergies from merging with Pharma Inc. will be $25 million The Flu-X LLC offer Flu-X LLC offers a cash payment of $5 dollars per Pharma Inc. share plus 20 shares of Flu-X LLC per Pharma Inc. share Flu-X LLC has 100 million shares outstanding trading at $1.50 per share. Flu-X LLC estimates that the synergy gains from merging with Pharma Inc. will be $42.5 million . D Question 31 3 pts Refer to the information provided above re Pharma Inc.'s offer from Vax Co. The total cost of the acquisition for Vax Co, Is Select The NPV of the acquisition is Select Vax Co, should Select) with the acquisition of Pharm Inc Question 32 2 pts Rafata thailoformation We Dharamsafoss